REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pet Suplet Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pet Suplet Sas Profile Updated: June 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Pet Suplet Sas is a company based in Colombia, with its head office in Bogota D.C.. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on February 10, 2020. There are currently 86 (2025) people employed by Pet Suplet Sas. The company’s latest financial report indicates a net sales revenue increase of 18.23% in 2024. Over the same period, its total assets grew by 69.36%.

Headquarters
Calle 77 68 G 68
Bogota D.C.; Bogota D.C; Postal Code: 0909

Contact Details: Purchase the Pet Suplet Sas report to view the information.

Basic Information
Total Employees:
Purchase the Pet Suplet Sas report to view the information.
Registered Capital:
Purchase the Pet Suplet Sas report to view the information.
Financial Auditors:
Purchase the Pet Suplet Sas report to view the information.
Incorporation Date:
February 10, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Pet Suplet Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
18.23%▲
Total operating revenue
18.23%▲
Operating profit (EBIT)
-22.26%▼
EBITDA
-21.81%▼
Net Profit (Loss) for the Period
N/A
Total Assets
69.36%▲
Total Equity
-2.72%▼
Operating Profit Margin (ROS)
-0.21%▼
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo